General, biopharmaceutical corporations on the lookout to generate MAbs have an interest in preserving the specified quality attributes on the antibodies when lessening time and energy to market place and the costs linked to their production. Cationic lipid transfection: this technique leverages the benefit of fusion of liposomes with cationic pol